NCT07400289 Development of a FibroScan Liver Examination Using a Single Probe
| NCT ID | NCT07400289 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Echosens |
| Condition | Liver Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 309 participants |
| Start Date | 2025-11-14 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 309 participants in total. It began in 2025-11-14 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an exploratory, international, prospective, interventional, multicenter clinical investigation that will take place in 1 Hong Kong site and 3 French sites and 309 adults patients will be included. The study objective is to assess the LSM reproducibility between the FibroScan examination performed with the Single Probe (SP) and the FibroScan examination performed with the reference probes (M and XL).
Eligibility Criteria
Inclusion Criteria: * Adult patients (≥ 18 years of age). * Patient followed with a chronic liver disease. * Adult patient able to give his written consent. * For European sites: patient affiliated to the healthcare system. Exclusion Criteria: * Vulnerable patients. * Patients with ascites. * Patients with heart failure. * Patients with acute hepatitis. * Patients with biliary obstruction.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07400289 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Liver Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07400289 currently recruiting?
Yes, NCT07400289 is actively recruiting participants. Contact the research team at anne.llorca@echosens.com for enrollment information.
Where is the NCT07400289 trial being conducted?
This trial is being conducted at Besançon, France, Montpellier, France, Orsay, France, Hong Kong, Hong Kong.
Who is sponsoring the NCT07400289 clinical trial?
NCT07400289 is sponsored by Echosens. The trial plans to enroll 309 participants.